HopeStage
Back to all studies
CompletedNCT00247624

Sleep medicine and fluoxetine for depression with insomnia

About this titleRead the official source — NCT00247624
Medication studyAges 18–70United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 70 years.

Listed locations
Winston-SalemSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateOctober 2005
Recruitment status
Completed
Enrollment listed in the registry
60
Sponsor
Wake Forest University Health Sciences
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT00247624
Official title
Show the full official title

Hypnotics in the Treatment of Psychiatric Disorders

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Winston-Salem

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Wake Forest University Health Sciences, a university.

Did this study involve medication?

Yes. The study involved medication, including Eszopiclone, Fluoxetine and Placebo.

Who was this study for?

Listed age limits: 18 years to 70 years.

Want to explore more studies?

Explore studies